Superstring Capital
Overview
Superstring Capital is a venture capital firm based in New York City, focusing on early-stage investments in biotechnology and life sciences companies. Founded in 2019, the firm has made 12 investments, with its most recent being in May 2024 in Zenas BioPharma. Superstring Capital has raised two funds, including the Superstring Capital Onshore Fund, and has made two diversity investments, notably in Century Therapeutics and ReCode Therapeutics. The firm's portfolio includes companies such as Zenas BioPharma, Century Therapeutics, and LakeShore Biopharma. Superstring Capital's investment strategy emphasizes long-term, science-driven approaches, aiming to support innovative companies that are developing transformative therapies and technologies in the life sciences sector.
Investment Focus
- Companies must be in the biotechnology or life sciences sectors
- Preference for early-stage companies with innovative technologies
- Focus on companies developing transformative therapies and technologies
- Interest in companies with strong scientific foundations and potential for significant impact in their respective fields
Portfolio Companies
Reach Superstring Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Superstring Capital
What sectors does Superstring Capital invest in?
Superstring Capital invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in New York, United States. Superstring Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Superstring Capital invest at?
Superstring Capital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1M - 50M.
Which regions does Superstring Capital invest in?
Superstring Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Superstring Capital invested in?
Superstring Capital's portfolio includes Zenas BioPharma, Century Therapeutics and LakeShore Biopharma.
How do I contact Superstring Capital?
Superstring Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
